Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-048396

SVP, General Counsel&Secretary acquired 20,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Mano Michael SVP, General Counsel&Secretary 2022-08-31 Grant or award +20,000 83,000 D
Derivatives
Mano Michael SVP, General Counsel&Secretary 2022-08-31 Grant or award · Stock Option (right to buy) +30,000 30,000 D
Loading xslF345X03/doc4.xml…